Browse Drug Recalls
1,309 FDA drug safety recalls.
FDA Drug Recall Enforcement Database
Browse 1,309 FDA drug recall enforcement actions. Each entry includes the product description, reason for recall, classification (Class I through III based on severity), recalling firm, and distribution details. Use the filters below to search by year, classification, state, or keyword.
Drug Safety Recalls
Browse 1,309 FDA drug recalls in 2014.
| Date | Product | Reason | Class | Firm |
|---|---|---|---|---|
| Oct 6, 2014 | PROCAINE HCL (BUFF), 1%, injectable, 10 mL glass vial, RX, Creative Compounds... | Lack of Sterility Assurance: All lots of sterile products compounded by the pharmacy that are not... | Class II | Oregon Compounding Centers, Inc. dba Creative C... |
| Oct 6, 2014 | EPINEPHRINE/WATER, preservative free 1:1000, injectable, 1 mL glass vial, RX,... | Lack of Sterility Assurance: All lots of sterile products compounded by the pharmacy that are not... | Class II | Oregon Compounding Centers, Inc. dba Creative C... |
| Oct 6, 2014 | PAPAVERINE/PHENTOLAMINE/PROSTAGLANDIN, 17.64mg/0.58mg/5.8mcg, injectable, 1.7... | Lack of Sterility Assurance: All lots of sterile products compounded by the pharmacy that are not... | Class II | Oregon Compounding Centers, Inc. dba Creative C... |
| Oct 6, 2014 | CEFTAZIDIME, 2.25mg/0.1mL, Injectable, 0.2 mL plastic syringe, RX, Creative C... | Lack of Sterility Assurance: All lots of sterile products compounded by the pharmacy that are not... | Class II | Oregon Compounding Centers, Inc. dba Creative C... |
| Oct 6, 2014 | HYDROXYPROGESTERONE CAPROATE (SESAME OIL), 250mg/mL, injectable, 5 mL glass v... | Lack of Sterility Assurance: All lots of sterile products compounded by the pharmacy that are not... | Class II | Oregon Compounding Centers, Inc. dba Creative C... |
| Oct 3, 2014 | Ketorolac Tromethamine INJECTION, USP, 30 mg per mL, a) 1 mL vial (NDC 25021-... | Incorrect or Missing Lot and/or Exp Date: Ketorolac Tromethamine Injection, is being recalled as... | Class II | Sagent Pharmaceuticals Inc |
| Oct 3, 2014 | CVS pharmacy, Pain Relieving Antiseptic Spray. Benzalkonium Cl 0.13% Lidocain... | Microbial Contamination of Non-Sterile Products: CVS Pharmacy Pain Relieving Antiseptic Spray tes... | Class II | Wisconsin Pharmacal Company |
| Oct 2, 2014 | Hydrocortisone Butyrate Cream 0.1%, Net Wt. 15 gm tubes, Rx only, Manufacture... | Subpotent Drug; for the active, HCB, and preservatives, Propylparaben and Butylparaben at the 18 ... | Class III | Valeant Pharmaceuticals International |
| Oct 2, 2014 | candesartan cilexetil, tablets, 16 mg, 90-count bottles, Rx only, Manufactur... | Failed Impurities/Degradation Specifications: An Out of Specification (OOS) result was generated ... | Class III | Sandoz, Inc |
| Oct 2, 2014 | VERSAPHARM INCORPORATED Ethambutol Hydrochloride Tablets, USP, 100 mg, 100-co... | Subpotency: Out of Specification (OOS) result at the 36 month routine stability time point. | Class II | West-Ward Pharmaceutical Corp. |
| Oct 2, 2014 | Locoid (hydrocortisone butyrate 0.1%), Cream, Net Wt. 15 gm tubes, Rx only, M... | Subpotent Drug; for the active, HCB, and preservatives, Propylparaben and Butylparaben at the 18 ... | Class III | Valeant Pharmaceuticals International |
| Oct 1, 2014 | Amlodipine Besylate Tablets, USP 10 mg, Rx Only, 90 Tablets per bottle, Manuf... | Discoloration: Brown spots were noted embedded in Amlodipine Besylate Tablets, 10 mg, Lot # MP4344. | Class III | Zydus Pharmaceuticals USA Inc |
| Oct 1, 2014 | Emtriva (emtricitabine) Oral Solution, 10 mg/mL, 170 mL bottles, Rx only, Man... | Defective Container; leaking around the cap | Class II | Gilead Sciences, Inc. |
| Oct 1, 2014 | HYDROXYPROGESTERONE CAPROATE 250 MG/ML (IN SESAME OIL), Rx Only 4 mL INJECTAB... | Crystallization: Formation of crystals observed in product. | Class II | Avella of Deer Valley, Inc. |
| Oct 1, 2014 | Hydromorphone Hydrochloride Injection, USP, 10 mg/mL, Rx only, packaged in a)... | Lack Of Assurance Of Sterility: Confirmed customer complaints of glass product container vials th... | Class II | Hospira Inc. |
| Sep 30, 2014 | Truvada (200 mg emtricitabine and 300 mg tenofovir disoproxil fumarate) table... | Presence of Foreign Substance: Truvada was found to contain small red silicone rubber particulates. | Class III | Gilead Sciences, Inc. |
| Sep 29, 2014 | DOPamine Hydrochloride and 5% Dextrose INJ, USP, 200 mg per 250 mL, Rx Only, ... | Lack of Assurance of Sterility: A small cut in the solution bag may have been introduced during t... | Class II | Baxter Healthcare Corp. |
| Sep 26, 2014 | Bystolic (nebivolol) tablets, 20 mg/tablet, packaged as 7 tablets/bottle/cart... | Failed Dissolution Specification; at the 6-month stability time point | Class II | Forest Pharmaceuticals Inc |
| Sep 26, 2014 | Venlafaxine Hydrochloride Extended-Release Tablets, 37.5 mg, 30-count bottles... | Failed Dissolution Specifications; 12 month stability time point | Class II | Sun Pharma Global Inc. |
| Sep 26, 2014 | Diclofenac Sodium and Misoprostol Delayed-Release Tablets, 75 mg/0.2 mg, 60-c... | Failed Tablet/Capsule Specifications: Presence of split or broken tablets. | Class II | Actavis Laboratories, FL, Inc. |
| Sep 24, 2014 | BENZONATATE Capsules, USP, 200 mg, 100 Capsule Bottles, Rx only. Manufactured... | Presence of Foreign Capsules/Tablets: Benzonatate 100 mg co-mingled with benzonatate 200 mg capsu... | Class III | Zydus Pharmaceuticals USA Inc |
| Sep 22, 2014 | CEPHALEXIN MONOHYDRATE CAPSULES,USP, 500 mg, 20-count bottle, Rx only, Manufa... | CGMP deviations: Products were manufactured with active pharmaceutical ingredients that were not ... | Class II | Physicians Total Care, Inc. |
| Sep 22, 2014 | LOSARTAN POTASSIUM TABLETS USP, 25 mg, 1000 Tablet Bottles, Rx Only. Manufact... | Failed Content Uniformity Specifications; Dry mix failed blend uniformity. | Class II | Micro Labs Usa, Inc ... |
| Sep 18, 2014 | E-Z- GAS II EFFERVESCENT GRANULES Antacid/Antiflatulent ,4 g (0.14 oz), 50 -c... | Subpotent Drug: Out of Specification (OOS) result during routine stability testing at 24 months. | Class III | Bracco Diagnostic Inc |
| Sep 17, 2014 | Xarelto (rivaroxaban) Tablets 15 mg per tablet, 5 count bottle, Rx Only, Manu... | Microbial Contamination of Non-Sterile Products: Consumer complaint confirmed microbial contamin... | Class II | Janssen Ortho L.L.C. |
| Sep 15, 2014 | CREON (pancrelipase) Delayed-Release Capsules, Lipase 24,000 USP Units, 250 C... | Presence of Foreign Tablets/Capsules; Presence of co-mingled LipaCreon 13000. | Class II | AbbVie Inc |
| Sep 15, 2014 | Assured Aspirin Enteric Safety Coated Tablets, 81 mg, Adult Low Strength, Pai... | Subpotent Drug: Product failed to meet USP Specifications on assay, content uniformity, and disso... | Class II | American Family Pharmacy, LLC |
| Sep 15, 2014 | TOPIRAMATE Tablets 200 mg, 60 Tablet Bottles, Rx Only. Manufactured by Cadila... | Presence of Foreign Tablets: Presence of topiramate 100 mg tablets comingled with 200 mg tablets. | Class II | Zydus Pharmaceuticals USA Inc |
| Sep 15, 2014 | Tarceva (erlotinib) Tablets, 150 mg, 30 count bottle, Rx only, Manufactured ... | Failed Dissolution Specifications: The product did not meet the acceptance criteria for the disso... | Class II | Astellas Pharma US Inc |
| Sep 12, 2014 | Amiodarone HCl Injection, 450 mg/9 mL (50 mg per mL), 9 mL Single-Use Vial, R... | Temperature Abuse: One shipment was inadvertantly stored refrigerated rather than the labeled roo... | Class II | Mckesson |
| Sep 11, 2014 | HEPARIN SODIUM, 1000 USP Heparin Units/500 mL (2 USP Heparin Units/mL), in 0.... | Presence of Particulate Matter: A particulate, confirmed as human hair, was found sealed between ... | Class I | Hospira Inc. |
| Sep 11, 2014 | MethylPREDNISolone TABLETS, USP 4 mg, a) 100 count bottles (NDC 0603-4593-21)... | Subpotent; 6 month stability time point | Class III | Qualitest Pharmaceuticals |
| Sep 9, 2014 | Buprenorphine Hydrochloride Injection, CIII, 0.3 mg base/mL ,1 mL, 10 Carpuj... | Failed Impurities/Degradation Specification: Out of Specification results for pseudobuprenorphine... | Class II | Hospira Inc. |
| Sep 8, 2014 | Potassium Chloride Injection, 10 mEq per 100 mL, Highly Concentrated (100 mEq... | Correct Labeled Product Mispack: Shipping cartons labeled as containing Potassium Chloride inject... | Class II | Baxter Healthcare Corp |
| Sep 5, 2014 | Magnesium Chloride 20% (200mg/mL) Sterile Injection, 50mL Multi-Dose Vial, Rx... | Non-Sterility: Failing sterility results were obtained from the recalling firm's contract testing... | Class I | Pharmacy Creations |
| Sep 5, 2014 | Tropi/Cyclo/Phenyl/Tobra/Flurb (1/1/10/0.3/0.03)% Sterile Ophthalmic Solution... | Non-Sterility: Failing sterility results were obtained from the recalling firm's contract testing... | Class I | Pharmacy Creations |
| Sep 5, 2014 | Glutathione 100mg/mL Sterile Injection, 30 mL Multi Dose Vial, Rx only, Pharm... | Non-Sterility: Failing sterility results were obtained from the recalling firm's contract testing... | Class I | Pharmacy Creations |
| Sep 5, 2014 | Ascorbic Acid 500 mg/mL Sterile Injection, 50mL Multi-dose Vial, Rx only, Ph... | Non-Sterility: Failing sterility results were obtained from the recalling firm's contract testing... | Class I | Pharmacy Creations |
| Sep 4, 2014 | Bupivacaine HCl Inj., USP, 0.5% (5 mg/mL), 30 mL Single-dose Preservative-Fre... | Presence of Particulate Matter: A confirmed customer complaint reported the presence of a brown,... | Class II | Hospira Inc. |
| Aug 28, 2014 | FLUOCINONIDE GEL USP, 0.05%, Rx only, For External Use Only, Not For Ophthalm... | Failed Stability Specifications: The lots of Fluocinonide Gel USP, 0.05% recalled, may not meet t... | Class II | Fougera Pharmaceuticals Inc. |
| Aug 28, 2014 | Oxycodone and Acetaminophen Tablets USP 10 mg/325 mg 100 count bottles Rx Onl... | Failed Content Uniformity Specifications - The lot failed to meet the acceptance criteria for Uni... | Class II | Alvogen, Inc |
| Aug 28, 2014 | Dermatend Original, mole, wart and skin tag remover, For external use only, I... | Labeling: Labeling Bears Unapproved Claims; Dermatend is not FDA approved and therefore has not b... | Class II | Solace International Inc |
| Aug 28, 2014 | Dermatend Ultra, mole, wart and skin tag remover, For external use only, Ingr... | Labeling: Labeling Bears Unapproved Claims; Dermatend is not FDA approved and therefore has not b... | Class II | Solace International Inc |
| Aug 27, 2014 | Dihydroergotamine mesylate 1 mg/mL injection solution packaged in an amber gl... | Lack of Assurance of Sterility: Martin Avenue Pharmacy, Inc. is conducting a voluntary recall of ... | Class II | Martin Avenue Pharmacy, Inc. |
| Aug 27, 2014 | Nalbuphine 10 mg/mL injection solution packaged in an amber glass injectable ... | Lack of Assurance of Sterility: Martin Avenue Pharmacy, Inc. is conducting a voluntary recall of ... | Class II | Martin Avenue Pharmacy, Inc. |
| Aug 27, 2014 | Fentanyl/bupivacaine 3000 mcg/30 mg/mL injectable packaged in 30 mL or 60 mL ... | Lack of Assurance of Sterility: Martin Avenue Pharmacy, Inc. is conducting a voluntary recall of ... | Class II | Martin Avenue Pharmacy, Inc. |
| Aug 27, 2014 | Tri-mix, 15 mg/0.5 mg/10 mcg/mL (papaverine, phentolamine mesylate, alprostad... | Lack of Assurance of Sterility: Martin Avenue Pharmacy, Inc. is conducting a voluntary recall of ... | Class II | Martin Avenue Pharmacy, Inc. |
| Aug 27, 2014 | Bacteriostatic water for injection packaged in an amber glass injectable vial... | Lack of Assurance of Sterility: Martin Avenue Pharmacy, Inc. is conducting a voluntary recall of ... | Class II | Martin Avenue Pharmacy, Inc. |
| Aug 27, 2014 | Prednisolone acetate 50 mg/mL injectable packaged in an amber glass injectabl... | Lack of Assurance of Sterility: Martin Avenue Pharmacy, Inc. is conducting a voluntary recall of ... | Class II | Martin Avenue Pharmacy, Inc. |
| Aug 27, 2014 | Tri-mix T106, 30 mg/1 mg/25 mcg/mL (papaverine, phentolamine mesylate, alpros... | Lack of Assurance of Sterility: Martin Avenue Pharmacy, Inc. is conducting a voluntary recall of ... | Class II | Martin Avenue Pharmacy, Inc. |
Frequently Asked Questions
When a drug safety issue is identified — through FDA inspections, laboratory testing, adverse event reports, or manufacturer quality checks — the responsible company issues a recall to remove the affected products from the market. Pharmacies pull the product from shelves, and consumers are advised to contact their healthcare provider for alternatives.
The leading causes include cGMP deviations, impurity contamination (including nitrosamines like NDMA), failed dissolution or stability testing, sterility issues, potency problems, labeling errors, and foreign particle contamination.
Use the search and filter tools on this page to look up specific medications, active ingredients, or manufacturers. Each recall entry includes the product description, lot numbers, and distribution details.